They have internal embargo periods which vary by sets of donors across different cohorts and will typically span between now until early 2025.
They want to grant select institutions of collaborators limited view access to sets of donors with the ability to download molecular and clinical data.
The would like different collaborators to have access to different subsets of donors
P1000-US is collaborating with ~10 institutions.